NovoRapid injection Penfill, manufactured by Novo Nordisk Pharma, contains Insulin lispro (recombinant) and is used to treat diabetes mellitus in adults and children. It is a rapid-acting insulin typically administered immediately before a meal, with a standard of 300 units per kit (YJ code: 2492415A2035).
NovoRapid injection Penfill
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).